The market eventually and always rewards WINNERS right Samsa...and that's EXACTLY what IPCI's about to become throughout 2017 :)
So despite the ongoing market malaise of not running to the moon just yet despite submitting their Rexista NDA, receiving their PODRAS patent,securing the sweet SeroquelXR deal and initiating their profit sharing deal on PAR's 8 approved FocalinXR commercialized strengths...we all know the lingering effects of what happened to IPCI over the past 2 and a half years when the FDA came along and completely stalled IPCI's entire generics pipeline creating the persistent market conditions here that we're all anticipating will be over soon.
And during this time it's real easy for people to forget how much liquidity and share price action this stock was enjoying 3 full years ago on the heels of IPCI's 2 FocalinXR approvals.
In fact IPCI was an amazing trading stock for 6 full months directly on the heels of FocalinXR approval until the cold harsh reality began to kick in during May 2014 that the rest of their tentatively approved FocalinXR strengths weren't going to be launched due to TEVA's inability to even manufacture Focalin let alone launch their approved strengths.
That unfortunate negative market event was followed by the FDA then coming along a year later and asking IPCI to do more BE studies on FocalinXR 40mg as we all know...which along with a couple of small financings completely sucked the life out of this stock and created a plethora of questions surrounding IPCI's entire stalled/delayed generics pipeline.
However that's all slowly been changing over the past 6 months as IPCI's slowly but surely been turning a major corner and getting some major catalysts in the hopper.
So one of the only MAJOR lingering problems right now from where I sit is the fact that IPCI's CEO is so deftly against promoting his stock...and is more than content to let his upcoming results do all the talking for him whenever those days finally begin arriving.
Is he adopting this approach due to the significance of his npodds and PODRAS delivery tech platform potential? Only he knows! But one thing's for certain that it sucks the big one when we compare IPCI to its competitors and we see ALL of them being covered by a lot more analysts than IPCI...and we see ALL of them being heavily promoted by a wide variety of means(especially during catalysts)...something IPCI never does.
But there's no chance whatsoever that a major lucrative Rexista partnership announcement doesn't change how the big boys view IPCI moving forward...especially if the pending Rexista partnership also includes Oxtenda...the potential of such a partnership is that HUGE!
I mean it seriously sucks that way back in 2010 when this company barely had any imminent potential Dr Odidi was all over mainstream media channels ensuring he was getting the word out on this stock...but over the past 2.5 years has done everything in his power to not promote IPCI at all...save for Domenic doing an investor presentation once every few months.
What happened to ringing the opening bell on the NAZ for example? Why was Dr. Odidi willing to do that 3 years ago yet has never re-scheduled despite having a standing open invitation to do so ever since Storm Sandy act of nature cancelled IPCI's last ringing of the opening bell appearance on the NAZ?
IPCI's suffering from a severe lack of any relevant coverage anywhere at a time where/when they're on the verge of securing a massive Rexista deal...and that is 100% on Dr. Odidi's shoulders because only he knows the reason why!
I personally don't care that he is a scientist more than a seasoned PubCo CEO...and have no problem continuing to support his CEO position. But there eventually comes a time in all PubCo's lifetimes that they have to make a decision to compete in the ultra-competitive market landscape not just build a value-driven company...so I sincerely hope that that is part of Dr. Odidi's behind the scenes plans...because what better time to finally re-schedule the ringing of the opening bell on the Nasdaq Exchange than upon securing a MAJOR Rexista partnership right?
There's dozens upon dozens of bio analysts, bloggers, writers out there...and it would sure be a welcome surprise to see IPCI finally getting covered by them instead of ZERO attention being paid towards the market side of the always in motion equation which has sadly been the case here for 3 years running now.
News 
Market Data 
Discover 
